Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Microbiology and Immunology|December 10, 1999
Characterization of an outer membrane protein gene, pgmA, and its gene product from Porphyromonas gingivalisH Hongo, E Osano, M Ozeki, et al.Nihon Sanka Fujinka Gakkai Zasshi|December 1, 1991
[Detection of human papillomavirus types 16, 18 and 33 in exfoliated cervical cells by polymerase chain reaction]Y Takahashi, T Onoe, T Chiba, et al.Transplantation Proceedings|March 14, 2012
Complex vascular reconstruction using donor's vessel grafts in orthotopic liver transplantationS Shimizu, T Onoe, K Ide, et al.Japanese Circulation Journal|February 1, 1983
Malignant fibrous histiocytoma of the heartK Mori, H Itoh, H Kanaya, et al.Transplantation Proceedings|April 29, 2014
Multiple hepatic vein reconstruction using an all-in-one sleeve patch graft technique in living donor liver transplantation: a case reportS Shimizu, T Onoe, K Ishiyama, et al.Oral Microbiology and Immunology|February 1, 1992
Phenotypic characteristics and DNA relatedness in Prevotella intermedia and similar organismsH Fukushima, H Moroi, J Inoue, et al.Transplantation Proceedings|August 16, 2011
Kinetics of cellular and humoral immunity in a successful case of positive crossmatch kidney transplantation: a case reportN Tanimine, K Ide, M Yamashita, et al.Transplantation Proceedings|June 6, 2012
Renal vein extension using an autologous renal vein in a living donor with double inferior vena cava: a case reportH Sakai, K Ide, K Ishiyama, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2018
Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02)M Tahara, N Kiyota, T Yokota, et al.ESMO Open|June 4, 2024
A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibodyT Koyama, N Kiyota, S Boku, et al.Pageof 4